REPLIMUNE GROUP, INC. Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2025-06-30 was $2.00K.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2024-06-30 was $0.00.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for the quarter ending 2023-09-30 was $1.00K.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2026 was $2.00K.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2025 was $0.00.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2024 was $0.00.
- REPLIMUNE GROUP, INC. stock issued during period, value, restricted stock award, net of forfeitures for fiscal 2023 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 3 month | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.00K 10-K · filed 2026-06-29 | |
| 2025-06-30 | $2.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-K · filed 2026-06-29 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $0.00 10-K · filed 2025-05-22 | |
| 2023-09-30 | $1.00K 10-Q · filed 2025-02-12 | |
| 2023-03-31 | $0.00 10-K · filed 2023-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |